Examine the relationship genotypes (PAH) and phenotype in patients with phenylketonuria Rostov region
https://doi.org/10.1234/XXXX-XXXX-2016-6-3-10
Abstract
In the framework of genetic-epidemiological studies of the Rostov region in 131 patients with phenylketonuria were analyzed for DNA diagnostics, indicators of the level of phenylalanine and according to clinical manifestations of the disease from the genotype of the patients. In 130 patients with phenylketonuria detected 40 mutations (49 different genotypes) in the gene РАН , one in the gene PTS. The analysis of Geno-phenotypic correlations, studied the relationship between genotypes and indices of phenylalanine before treatment and on a background of spent therapy. During the study, the results obtained suggest that depending on the clinical picture of phenylketonuria from РАН genotype. Regression analysis showed a significant negative correlation between the activity of the enzyme phenylalanine hydroxylase and indicators of the level of phenylalanine in patients with repeated analysis and a result of diet.
About the Authors
M. A. Amelina
Southern Federal University
Russian Federation
Russian Federation
R. A. Zinchenko
Research Centre for Medical Genetics; Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
A. A. Stepanova
Research Centre for Medical Genetics
Russian Federation
Russian Federation
P. . Gundorova
Research Centre for Medical Genetics
Russian Federation
Russian Federation
A. V. Polyakov
Research Centre for Medical Genetics
Russian Federation
Russian Federation
S. S. Amelina
Rostov State Medical University
Russian Federation
Russian Federation
References
1. http://omim.org/
2. Fitzpatrick P.F. Allosteric Regulation of Phenylalanine Hydroxylase // Arch. Biochem. Biophys. - 2012. - Mar. 15. - Vol. 519(2). - Р. 194-201.
3. http://www.biopku.org
4. Mitchell J.J. Phenylalanine Hydroxylase Deficiency GeneReviews [Internet]. - Seattle (WA): University of Washington, Seattle; 2013. ISSN: 2372-0697.
5. http://www.espku.org
6. Blau N. Genetics of Phenylketonuria: Then and Now // Hum. Mutat. - 2016. - Feb. 26. doi: 10.1002/humu.22980.
7. http://ghr.nlm.nih.gov
8. Kayaalp E., Treacy E., Waters P.J., Byck S. et al. Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations // Am. J. Hum. Genet. - 1997. - Vol. 61. - Р. 1309-1317.
9. Scriver C.R., Waters P.J. Monogenic traits are not simple: lessons from phenylketonuria // Trends Genet. - 1999. - Vol. 15. - Р. 267-272.
10. Greeves L.G., Patterson C.C., Carson D.J. et al. Effect of genotype on changes in intelligence quotient after dietary relaxation in phenylketonuria and hyperphenylalaninaemia // Arch. Dis. Child. - 2000. - Vol. 82. - Р. 216-221.
11. Shen N., Heintz C., Thiel C. et al. Co-expression of phenylalanine hydroxylase variants and effects of interallelic complementation on in vitro enzyme activity and genotype-phenotype correlation // Mol. Genet. Metab. - 2016. - Vol. 117(3). - Р. 328-335. doi: 10.1016/j.ymgme.2016.01.004.
12. DiSilvestre D., Koch R., Groffen J. Different clinical manifestations of hyperphenylalaninemia in three siblings with identical phenylalanine hydroxylase genes // Am. J. Hum. Genet. - 1991. - Vol. 48. - Р. 1014-1016.
13. Pey A.L., Stricher F., Serrano L. et al. Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases // Am. J. Hum. Genet. - 2007. - Vol. 81(5). - Р. 1006-1024.
14. Vernon H.J., Koerner C.B., Johnson M.R., Bergner A., Hamosh A. Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria // Mol. Genet. Metab. - 2010. - Vol. 100. - Р. 229-233.
15. Амелина М.А., Степанова А.А., Поляков А.В., Амелина С.С., Зинченко Р.А. Спектр и частота мутаций в гене РАН у больных фенилкетонурией Ростовской области // Медицинская генетика. - 2015. - №2. - С. 8-9.
16. Karaciс I., Meili D., Sarnavka V., Heintz C. et al. Genotype-predicted tetrahydrobiopterin (BH4)-responsiveness and molecular genetics in Croatian patients with phenylalanine hydroxylase (PAH) deficiency // Mol. Genet. Metab. - 2009. - Jul. - Vol. 97(3). - Р. 165-171. doi: 10.1016/j.ymgme.2009.03.009. Epub 2009 Apr. 1.
17. Danecka M.K., Woidy M., Zschocke J. et al. Mapping the functional landscape of frequent phenylalanine hydroxylase (PAH) genotypes promotes personalised medicine in phenylketonuria // J. Med. Genet. - 2015. - Vol. 52(3). - Р. 175-185. doi: 10.1136/jmedgenet-2014-102621. Epub 2015 Jan 16.
Review
For citations:
Amelina M.A., Zinchenko R.A., Stepanova A.A., Gundorova P., Polyakov A.V., Amelina S.S. Examine the relationship genotypes (PAH) and phenotype in patients with phenylketonuria Rostov region. Medical Genetics. 2016;15(6):3-10. (In Russ.) https://doi.org/10.1234/XXXX-XXXX-2016-6-3-10
Views:
926
Email this article 